These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2015-004104-33 A Randomised, Parallel, Double Blinded Study to Compare the Efficacy and Safety of FKB238 to AvastinĀ® In 1st Line Treatment for Patients with Advanced/Recurrent Non Squamous Non-Small Cell Lung Cancer... 2022-01-26 due-trials